Similar Papers

Paper Title
Journal
Date
Author
Sorafenib In Combination with Standard Induction and Consolidation Therapy In Elderly AML Patients: Results From a Randomized, Placebo-Controlled Phase II Trial
Hubert Serve ...
Blood | VOL. 116
Hubert Serve, et. al.Hubert Serve ...
19 Nov 2010
Consolidation with autologous stem cell transplantation in first remission is safe and effective in AML patients above 65 years
Alexander D Heini ... Thomas Pabst
Leukemia Research | VOL. 53
Alexander D Heini, et. al.Alexander D Heini ... Thomas Pabst
08 Dec 2016
A Multicentre Phase II Study of the Aminopeptidase Inhibitor, CHR- 2797, in the Treatment of Elderly and/or Previously Treated patients with Acute Myeloid Leukemia.
B Lowenberg ... G Ossenkoppele
Blood | VOL. 112
B Lowenberg, et. al.B Lowenberg ... G Ossenkoppele
16 Nov 2008
Liposomal daunorubicin plus cytosine arabinoside for elderly patients with acute myeloid leukemia
M Vignetti ... A Camera
Experimental Hematology | VOL. 28
M Vignetti, et. al.M Vignetti ... A Camera
01 Dec 2000
View more papers

More From: Blood

Paper Title
Journal
Date
Author
Targeting CD47: many misses; hopeful for a hit.
Lindsay Wilde ... Margaret Kasner
Blood | VOL. 145
Lindsay Wilde, et. al.Lindsay Wilde ... Margaret Kasner
30 Jan 2025
c-MYC stain as a potential minimal residual disease marker for acute myeloid leukemia with NPM1 mutation.
Kirill A Lyapichev ... Amir Behdad
Blood | VOL. 145
Kirill A Lyapichev, et. al.Kirill A Lyapichev ... Amir Behdad
30 Jan 2025
A 3-pronged attack on TP53-mutated MCL.
Christine E Ryan ... Ann S Lacasce
Blood | VOL. 145
Christine E Ryan, et. al.Christine E Ryan ... Ann S Lacasce
30 Jan 2025
Advances in RNA editing in hematopoiesis and associated malignancies.
Shuangshuang Pu ... Hui Cheng
Blood | VOL. -
Shuangshuang Pu, et. al.Shuangshuang Pu ... Hui Cheng
27 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.